# National Survey on Infiltrative Breast Cancer

> **NCT00696527** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1500 (estimated)

## Conditions studied

- Infiltrative Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00696527
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2010-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00696527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00696527, "National Survey on Infiltrative Breast Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00696527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*